L. M. Mosiichuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
L. M. Mosiichuk has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Oksana Petishko
Institute of Gastroenterology of NAMSU, Dnipro, Ukraine
18 shared publications - O. M. Shevtsova
State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine
12 shared publications - O. M. Tatarchuk
State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine
10 shared publications - I. A. Klenina
State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine
8 shared publications - Yu. M. Stepanov
Institute of Gastroenterology of NAMSU, Dnipro, Ukraine
8 shared publications - E.V. Zyhalo
SI “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine
3 shared publications
Latest Publications
- Open Access
- 27 March 2026
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 60 (1) , 1-7
Influence of wartime factors on the development of metabolic disorders in military servicemen with erosive-ulcerative lesions of the esophagogastroduodenal zone
Background. Metabolic syndrome is one of the main factors that aggravate the course of erosive-ulcerative lesions of the esophagogastroduodenal zone, particularly in military personnel. Identification of wartime factors that contribute to the development of metabolic disorders in this category of patients will allow timely implementation of preventive measures and treatment personalization. The purpose of the study: to identify risk factors for the development of metabolic disorders in military personnel with erosive-ulcerative lesions of the esophagogastroduodenal zone during wartime. Materials and methods. The study included 40 military personnel with erosive-ulcerative lesions of the esophagogastroduodenal zone: group I consisted of 27 patients without metabolic disorders (age was (37.74 ± 1.65) years, body mass index was (27.69 ± 0.91) kg/m2); group II included 13 patients with metabolic disorders (age was (39.00 ± 2.36) years, body mass index was (35.57 ± 0.83) kg/m2). To study the effect of wartime factors on a person, a questionnaire was developed, which included a whole range of questions regarding psycho-emotional suffering, physical exertion, nutritional characteristics, material and financial losses, etc. Results. According to the questionnaire data, 65.0 % patients indicated an increase in psycho-emotional exertion since the beginning of the war, and 40.0 % — in physical exertion. 57.5 % servicemen noted a violation of the diet, 72.5 % — a change in the quality of food, 67.5 % — sleep disturbances. At the time of hospitalization, the percentage of participants in group II who served in the rear was almost 3 times higher than in group I (53.8 versus 18.5 %, p = 0.055), which contributed to a decrease in their overall physical activity. The examined patients characterized their diet since the beginning of the war as follows: increased consumption of canned food (67.5 %), fast food (12.5 %), pasta and bread and bakery products (47.5 %) with a simultaneous decrease of fruits and vegetables (57.5 %), meat (32.5 %), fish (40.0 %) and hot food (50.0 %) in the diet, without significant differences between groups. A significant difference was noted in terms of increased fatty foods, which patients with metabolic syndrome consumed 3.6 times more often than those without metabolic disorders (p = 0.027). Irregular eating was indicated by 44.4 % servicemen in group I versus 84.6 % in group II (p = 0.039). Servicemen with erosive-ulcerative lesions of the esophagogastroduodenal zone and metabolic syndrome were 2 times more likely to report weight gain (p = 0.043) and increased heart rate (p = 0.072), 1.7 times more likely to report sleep disturbances (p = 0.049). Conclusions. Risk factors for the development of metabolic disorders in servicemen with erosive-ulcerative lesions of the esophagogastroduodenal zone during wartime, according to the questionnaire data, were irregular eating habits (odds ratio (OR) = 6.88; p = 0.025), an increase of fatty foods in the diet (OR = 6.71; p = 0.014), service in the rear (OR = 5.13; p = 0.028), and sleep disorders (OR = 9.60; p = 0.042). Identifying these factors will allow for timely formation of a risk group to provide military personnel with personalized prevention programs.
- 27 March 2026
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 60 (1) , 1-7
Open AccessInfluence of wartime factors on the development of metabolic disorders in military servicemen with erosive-ulcerative lesions of the esophagogastroduodenal zone
Background. Metabolic syndrome is one of the main factors that aggravate the course of erosive-ulcerative lesions of the esophagogastroduodenal zone, particularly in military personnel. Identification of wartime factors that contribute to the development of metabolic disorders in this category of patients will allow timely implementation of preventive measures and treatment personalization. The purpose of the study: to identify risk factors for the development of metabolic disorders in military personnel with erosive-ulcerative lesions of the esophagogastroduodenal zone during wartime. Materials and methods. The study included 40 military personnel with erosive-ulcerative lesions of the esophagogastroduodenal zone: group I consisted of 27 patients without metabolic disorders (age was (37.74 ± 1.65) years, body mass index was (27.69 ± 0.91) kg/m2); group II included 13 patients with metabolic disorders (age was (39.00 ± 2.36) years, body mass index was (35.57 ± 0.83) kg/m2). To study the effect of wartime factors on a person, a questionnaire was developed, which included a whole range of questions regarding psycho-emotional suffering, physical exertion, nutritional characteristics, material and financial losses, etc. Results. According to the questionnaire data, 65.0 % patients indicated an increase in psycho-emotional exertion since the beginning of the war, and 40.0 % — in physical exertion. 57.5 % servicemen noted a violation of the diet, 72.5 % — a change in the quality of food, 67.5 % — sleep disturbances. At the time of hospitalization, the percentage of participants in group II who served in the rear was almost 3 times higher than in group I (53.8 versus 18.5 %, p = 0.055), which contributed to a decrease in their overall physical activity. The examined patients characterized their diet since the beginning of the war as follows: increased consumption of canned food (67.5 %), fast food (12.5 %), pasta and bread and bakery products (47.5 %) with a simultaneous decrease of fruits and vegetables (57.5 %), meat (32.5 %), fish (40.0 %) and hot food (50.0 %) in the diet, without significant differences between groups. A significant difference was noted in terms of increased fatty foods, which patients with metabolic syndrome consumed 3.6 times more often than those without metabolic disorders (p = 0.027). Irregular eating was indicated by 44.4 % servicemen in group I versus 84.6 % in group II (p = 0.039). Servicemen with erosive-ulcerative lesions of the esophagogastroduodenal zone and metabolic syndrome were 2 times more likely to report weight gain (p = 0.043) and increased heart rate (p = 0.072), 1.7 times more likely to report sleep disturbances (p = 0.049). Conclusions. Risk factors for the development of metabolic disorders in servicemen with erosive-ulcerative lesions of the esophagogastroduodenal zone during wartime, according to the questionnaire data, were irregular eating habits (odds ratio (OR) = 6.88; p = 0.025), an increase of fatty foods in the diet (OR = 6.71; p = 0.014), service in the rear (OR = 5.13; p = 0.028), and sleep disorders (OR = 9.60; p = 0.042). Identifying these factors will allow for timely formation of a risk group to provide military personnel with personalized prevention programs.
- Open Access
- 29 September 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (3) , 174-180
Hyperleptinemia in patients with gastroesophageal reflux disease and obesity: approaches to the assessment and prevention of leptin resistance
Background. Gastroesophageal reflux disease (GERD) and obesity remain the most common comorbid pathology, which significantly affects the deterioration of the quality of life of patients. Many studies have been conducted to determine the factors contributing to the development of these diseases, but the role of leptin remains the most debatable issue. Currently, there are no clear criteria for effective assessment of leptin sensitivity in clinical settings, although some researchers consider hyperleptinemia to be a key marker of leptin resistance. The aim is to substantiate approaches to the assessment and prevention of leptin resistance in patients with GERD and obesity. Materials and methods. Sixty men with GERD and obesity were examined and divided into three groups depending on the leptin level. All patients had serum levels of tumor necrosis factor alpha, interleukin 6, leptin, insulin, total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, atherogenic index and insulin resistance index calculated. To assess anxiety syndrome and body exhaustion, precise diagnostics was used on the CONTEC 8000GW cardiograph. Body composition analysis was performed using TANITA MC-780MA scale analyzers (Japan). Results. 38.2 % of patients with hyperleptinemia were diagnosed with anxiety syndrome, 52.9 % with exhaustion, 44.1 % with sleep disorders, and 64.7 % had a dangerous amount of visceral fat. Direct correlations of leptin with hyperinsulinemia (r = 0.316; p = 0.015), insulin resistance (r = 0.302; p = 0.020), increased levels of triglycerides (r = 0.414; p = 0.003), very low-density lipoprotein cholesterol (r = 0.381; p = 0.006) and interleukin 6 (r = 0.507; p < 0.001) were found. To assess leptin resistance, the ratio of leptin to triglyceride level was used, which in patients with GERD with degree 1 obesity was (6.07 ± 0.81) conventional units, with degree 2 obesity — (11.64 ± 1.44) conventional units, with degree 3 obesity — (14.54 ± 2.26) conventional units (F = 11.67; p < 0.0001). In the presence of a dangerous amount of visceral fat, the leptin resistance coefficient increased by 1.6 times compared to patients with GERD with a safe level of visceral fat (t = 2.80; p = 0.008). Insulin resistance was associated with a significant increase in the leptin resistance coefficient — by 2.5 times (t = 4.98; p < 0.0001). According to the results of regression analysis, it was found that the ratio of leptin to triglyceride level above 8.43 conventional units with a sensitivity of 62.9 % and a specificity of 96.0 % can be used as a minimally invasive marker for assessing leptin resistance. Conclusions. Reasoned approaches to the assessment and prevention of leptin resistance in patients with GERD and obesity will contribute to increasing the effectiveness of treatment measures.
- 29 September 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (3) , 174-180
Open AccessHyperleptinemia in patients with gastroesophageal reflux disease and obesity: approaches to the assessment and prevention of leptin resistance
Background. Gastroesophageal reflux disease (GERD) and obesity remain the most common comorbid pathology, which significantly affects the deterioration of the quality of life of patients. Many studies have been conducted to determine the factors contributing to the development of these diseases, but the role of leptin remains the most debatable issue. Currently, there are no clear criteria for effective assessment of leptin sensitivity in clinical settings, although some researchers consider hyperleptinemia to be a key marker of leptin resistance. The aim is to substantiate approaches to the assessment and prevention of leptin resistance in patients with GERD and obesity. Materials and methods. Sixty men with GERD and obesity were examined and divided into three groups depending on the leptin level. All patients had serum levels of tumor necrosis factor alpha, interleukin 6, leptin, insulin, total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, atherogenic index and insulin resistance index calculated. To assess anxiety syndrome and body exhaustion, precise diagnostics was used on the CONTEC 8000GW cardiograph. Body composition analysis was performed using TANITA MC-780MA scale analyzers (Japan). Results. 38.2 % of patients with hyperleptinemia were diagnosed with anxiety syndrome, 52.9 % with exhaustion, 44.1 % with sleep disorders, and 64.7 % had a dangerous amount of visceral fat. Direct correlations of leptin with hyperinsulinemia (r = 0.316; p = 0.015), insulin resistance (r = 0.302; p = 0.020), increased levels of triglycerides (r = 0.414; p = 0.003), very low-density lipoprotein cholesterol (r = 0.381; p = 0.006) and interleukin 6 (r = 0.507; p < 0.001) were found. To assess leptin resistance, the ratio of leptin to triglyceride level was used, which in patients with GERD with degree 1 obesity was (6.07 ± 0.81) conventional units, with degree 2 obesity — (11.64 ± 1.44) conventional units, with degree 3 obesity — (14.54 ± 2.26) conventional units (F = 11.67; p < 0.0001). In the presence of a dangerous amount of visceral fat, the leptin resistance coefficient increased by 1.6 times compared to patients with GERD with a safe level of visceral fat (t = 2.80; p = 0.008). Insulin resistance was associated with a significant increase in the leptin resistance coefficient — by 2.5 times (t = 4.98; p < 0.0001). According to the results of regression analysis, it was found that the ratio of leptin to triglyceride level above 8.43 conventional units with a sensitivity of 62.9 % and a specificity of 96.0 % can be used as a minimally invasive marker for assessing leptin resistance. Conclusions. Reasoned approaches to the assessment and prevention of leptin resistance in patients with GERD and obesity will contribute to increasing the effectiveness of treatment measures.
- Open Access
- 25 March 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (1) , 8-15
Features of lipid metabolism in patients with erosive esophagitis during the period of martial law
Background. Over the past decades, the number of patients with erosive esophagitis in the world has increased. At the same time, metabolic syndrome and chronic stress are considered risk factors for the development of erosive esophagitis. The aim of the study: to determine the diagnostic significance of lipid metabolism indicators for the formation of a group at risk of developing erosive esophagitis among patients with gastroesophageal reflux disease and overweight during the period of martial law. Materials and methods. The study included 40 men with gastroesophageal reflux disease and overweight. The subjects were aged from 20 to 57 years, the average age was (42.8 ± 1.2) years. According to the results of esophagogastroduodenoscopy with narrow band imaging, 25 patients were diagnosed with erosive esophagitis, and 15 with non-erosive reflux disease. The serum levels of total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-С) were determined in all subjects using a Stat Fax 4500 biochemical analyzer (USA). Low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C) and atherogenic index (AI) were also calculated. Results. The average group content of TC in the blood serum of patients with erosive esophagitis was 1.2 times higher compared to the control group (p = 0.0083) due to the presence of hypercholesterolemia in 36.0 % of patients. Despite the fact that the median TG content in both groups did not exceed the reference values, hypertriglyceridemia was noted in 32 % of participants with erosive esophagitis. In addition, these patients, in contrast to the control group, had a significant decrease in HDL-C levels by 1.4 times (p = 0.0042) with a simultaneous 2-fold increase in VLDL-C (p = 0.0024) and a 1.8-fold in AI (p = 0.0069). In patients with erosive esophagitis, the ratios of TG/HDL-C, LDL-C/HDL-C and TC/HDL-C were, respectively, 1.4 times (p = 0.0246), 1.3 times (p = 0.0295) and 1.2 times (p = 0.0085) higher than in patients with non-erosive reflux disease. Patients with erosive esophagitis had direct correlations between body mass index and TG/HDL-C (r = 0.47; p = 0.0003), LDL-C/HDL-C (r = 0.34; p = 0.011) and TC/HDL-C (r = 0.44; p = 0.0007). Conclusions. The diagnostic criteria for the formation of a group at risk of developing erosive esophagitis among patients with gastroesophageal reflux disease and overweight during the period of martial law are the ratios of TG/HDL-C (sensitivity 78.6 %, specificity 87.5 %), TC/HDLC (sensitivity 82.1 %, specificity 62.5 %), LDL-C/HDL-C (sensitivity 75.0 %, specificity 56.2 %). Therefore, in case of contraindications or limited access to esophagogastroduodenoscopy, it is necessary to study lipid metabolism indicators and their correlations in patients with gastroesophageal reflux disease and overweight.
- 25 March 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (1) , 8-15
Open AccessFeatures of lipid metabolism in patients with erosive esophagitis during the period of martial law
Background. Over the past decades, the number of patients with erosive esophagitis in the world has increased. At the same time, metabolic syndrome and chronic stress are considered risk factors for the development of erosive esophagitis. The aim of the study: to determine the diagnostic significance of lipid metabolism indicators for the formation of a group at risk of developing erosive esophagitis among patients with gastroesophageal reflux disease and overweight during the period of martial law. Materials and methods. The study included 40 men with gastroesophageal reflux disease and overweight. The subjects were aged from 20 to 57 years, the average age was (42.8 ± 1.2) years. According to the results of esophagogastroduodenoscopy with narrow band imaging, 25 patients were diagnosed with erosive esophagitis, and 15 with non-erosive reflux disease. The serum levels of total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-С) were determined in all subjects using a Stat Fax 4500 biochemical analyzer (USA). Low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C) and atherogenic index (AI) were also calculated. Results. The average group content of TC in the blood serum of patients with erosive esophagitis was 1.2 times higher compared to the control group (p = 0.0083) due to the presence of hypercholesterolemia in 36.0 % of patients. Despite the fact that the median TG content in both groups did not exceed the reference values, hypertriglyceridemia was noted in 32 % of participants with erosive esophagitis. In addition, these patients, in contrast to the control group, had a significant decrease in HDL-C levels by 1.4 times (p = 0.0042) with a simultaneous 2-fold increase in VLDL-C (p = 0.0024) and a 1.8-fold in AI (p = 0.0069). In patients with erosive esophagitis, the ratios of TG/HDL-C, LDL-C/HDL-C and TC/HDL-C were, respectively, 1.4 times (p = 0.0246), 1.3 times (p = 0.0295) and 1.2 times (p = 0.0085) higher than in patients with non-erosive reflux disease. Patients with erosive esophagitis had direct correlations between body mass index and TG/HDL-C (r = 0.47; p = 0.0003), LDL-C/HDL-C (r = 0.34; p = 0.011) and TC/HDL-C (r = 0.44; p = 0.0007). Conclusions. The diagnostic criteria for the formation of a group at risk of developing erosive esophagitis among patients with gastroesophageal reflux disease and overweight during the period of martial law are the ratios of TG/HDL-C (sensitivity 78.6 %, specificity 87.5 %), TC/HDLC (sensitivity 82.1 %, specificity 62.5 %), LDL-C/HDL-C (sensitivity 75.0 %, specificity 56.2 %). Therefore, in case of contraindications or limited access to esophagogastroduodenoscopy, it is necessary to study lipid metabolism indicators and their correlations in patients with gastroesophageal reflux disease and overweight.
- Open Access
- 21 December 2024
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 58 (4) , 234-239
Characteristics of metabolic syndrome in the servicemen with erosive esophagitis in wartime conditions
Background. Among the well-known factors contributing to the prevalence of erosive esophagitis, the leading one is an increase in the number of individuals with obesity and insulin resistance. The assessment of metabolic syndrome in the servicemen of the Armed Forces of Ukraine with erosive esophagitis in wartime conditions is of particular importance, as the effectiveness of their professional activities depends on it. The purpose of the study: to evaluate the body composition and insulin resistance in the servicemen of the Armed Forces of Ukraine with erosive esophagitis, taking into account the level of the stress index, exhaustion and adaptative capacity of the body. Materials and methods. The study included 24 men aged 33 to 57 years, the average age was (42.7 ± 2.1) years. All military personnel were assessed for maladjustment, increased cardiovascular risk, anxiety, and fatigue using the cardiorhythmography method based on the analysis of heart rate variability on the CONTEC8000GW system. Body composition was assessed using Tanita MC-780МА (Japan) scales-analyzers whose mechanism is based on the technique of bioimpedance analysis with computer processing. Insulin resistance was evaluated using the HOMA-IR index, for the calculation of which the level of insulin was determined by enzyme-linked immunosorbent assay systems of the Xema company (Ukraine) on the Stat Fax 303 Plus analyzer (USA). Results. According to precise diagnostics, half of the servicemen of the Armed Forces of Ukraine with erosive esophagitis were diagnosed with vegetative imbalance, which was manifested by an increase in the stress index in 37.5 % of cases, a disruption or violation of adaptation in 25.0 %, and exhaustion of the body in 54.2 % of cases. The HOMA-IR index was 1.5 times higher (p = 0.006) compared to that of the control group. 37.5 % of the servicemen of the Armed Forces of Ukraine with erosive esophagitis showed signs of metabolic syndrome. Correlation analysis revealed relationship of heart rate variability with body composition indicators (body mass index, fat mass, and amount of visceral fat). In addition, an increase in insulin resistance is associated with an increase in the stress index and cardiovascular risk, as well as a decrease in the adaptive capacity of the body and its exhaustion. Conclusions. The correlations found between indicators of heart rate variability, insulin resistance and body composition will allow for the development of a personalized approach to the management of the servicemen of the Armed Forces of Ukraine with erosive esophagitis.
- 21 December 2024
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 58 (4) , 234-239
Open AccessCharacteristics of metabolic syndrome in the servicemen with erosive esophagitis in wartime conditions
Background. Among the well-known factors contributing to the prevalence of erosive esophagitis, the leading one is an increase in the number of individuals with obesity and insulin resistance. The assessment of metabolic syndrome in the servicemen of the Armed Forces of Ukraine with erosive esophagitis in wartime conditions is of particular importance, as the effectiveness of their professional activities depends on it. The purpose of the study: to evaluate the body composition and insulin resistance in the servicemen of the Armed Forces of Ukraine with erosive esophagitis, taking into account the level of the stress index, exhaustion and adaptative capacity of the body. Materials and methods. The study included 24 men aged 33 to 57 years, the average age was (42.7 ± 2.1) years. All military personnel were assessed for maladjustment, increased cardiovascular risk, anxiety, and fatigue using the cardiorhythmography method based on the analysis of heart rate variability on the CONTEC8000GW system. Body composition was assessed using Tanita MC-780МА (Japan) scales-analyzers whose mechanism is based on the technique of bioimpedance analysis with computer processing. Insulin resistance was evaluated using the HOMA-IR index, for the calculation of which the level of insulin was determined by enzyme-linked immunosorbent assay systems of the Xema company (Ukraine) on the Stat Fax 303 Plus analyzer (USA). Results. According to precise diagnostics, half of the servicemen of the Armed Forces of Ukraine with erosive esophagitis were diagnosed with vegetative imbalance, which was manifested by an increase in the stress index in 37.5 % of cases, a disruption or violation of adaptation in 25.0 %, and exhaustion of the body in 54.2 % of cases. The HOMA-IR index was 1.5 times higher (p = 0.006) compared to that of the control group. 37.5 % of the servicemen of the Armed Forces of Ukraine with erosive esophagitis showed signs of metabolic syndrome. Correlation analysis revealed relationship of heart rate variability with body composition indicators (body mass index, fat mass, and amount of visceral fat). In addition, an increase in insulin resistance is associated with an increase in the stress index and cardiovascular risk, as well as a decrease in the adaptive capacity of the body and its exhaustion. Conclusions. The correlations found between indicators of heart rate variability, insulin resistance and body composition will allow for the development of a personalized approach to the management of the servicemen of the Armed Forces of Ukraine with erosive esophagitis.
- Open Access
- 12 June 2024
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 58 (2) , 87-92
The role of fibroblast growth factor 21 in metabolic processes in patients with gastrointestinal diseases
Background. Recently, the number of patients with obesity and metabolic syndrome has increased. Numerous studies to find new regulators of metabolic processes have led to the discovery of a new fibroblast growth factor 21 (FGF21). The purpose of the study was to determine the correlation between FGF21 and metabolic processes among patients with gastrointestinal pathology. Materials and methods. The study was conducted in 80 patients with gastrointestinal diseases aged 18 to 66 years, the average age was (39.04 ± 1.03) years. Among the subjects, there were 56 men (70.0 %) and 24 women (30.0 %). Body composition was assessed using the Tanita MC-780MA apparatus (Japan). Serum leptin, FGF21, insulin levels were measured by enzyme-linked immunosorbent assay, and the HOMA-IR was calculated. Free fatty acids in the serum of patients were evaluated on Chromateс Crystal-5000, a gas chromatograph with a flame ionization detector. Results. The study found positive correlations between FGF21 levels and indicators of bioimpedance analysis: body mass index (r = 0.24; p = 0.004), fat mass (r = 0.26; p = 0.01) and visceral fat (r = 0.29; p = 0.01). In addition, a relationship was detected between FGF21 levels and laboratory data: insulin (r = 0.32; p = 0.001), HOMA-IR (r = 0.31; p = 0.001), leptin (r = 0.32; p = 0.001), triglyceride/high-density lipoprotein ratio (r = 0.48; p = 0.0001), and the content of certain free fatty acids. This indicates that FGF21 affects the development of obesity and metabolic disorders. It was found that FGF21 is associated with visceral obesity in patients with digestive diseases (odds ratio = 1.28, p = 0.0022). FGF21 levels above 1,317.5 pg/mL (sensitivity of 71.0 %, specificity of 53.1 %) indicate the presence of visceral obesity in patients with gastrointestinal diseases. Conclusions. As a result of a comprehensive study, new data were obtained on the role of FGF21 as a key regulator of metabolic disorders, which is confirmed by the established relationships of this indicator with the components of lipid and carbohydrate metabolism disorders, cytokine imbalance, and hormonal activity of adipose tissue in patients with pathology of the digestive system.
- 12 June 2024
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 58 (2) , 87-92
Open AccessThe role of fibroblast growth factor 21 in metabolic processes in patients with gastrointestinal diseases
Background. Recently, the number of patients with obesity and metabolic syndrome has increased. Numerous studies to find new regulators of metabolic processes have led to the discovery of a new fibroblast growth factor 21 (FGF21). The purpose of the study was to determine the correlation between FGF21 and metabolic processes among patients with gastrointestinal pathology. Materials and methods. The study was conducted in 80 patients with gastrointestinal diseases aged 18 to 66 years, the average age was (39.04 ± 1.03) years. Among the subjects, there were 56 men (70.0 %) and 24 women (30.0 %). Body composition was assessed using the Tanita MC-780MA apparatus (Japan). Serum leptin, FGF21, insulin levels were measured by enzyme-linked immunosorbent assay, and the HOMA-IR was calculated. Free fatty acids in the serum of patients were evaluated on Chromateс Crystal-5000, a gas chromatograph with a flame ionization detector. Results. The study found positive correlations between FGF21 levels and indicators of bioimpedance analysis: body mass index (r = 0.24; p = 0.004), fat mass (r = 0.26; p = 0.01) and visceral fat (r = 0.29; p = 0.01). In addition, a relationship was detected between FGF21 levels and laboratory data: insulin (r = 0.32; p = 0.001), HOMA-IR (r = 0.31; p = 0.001), leptin (r = 0.32; p = 0.001), triglyceride/high-density lipoprotein ratio (r = 0.48; p = 0.0001), and the content of certain free fatty acids. This indicates that FGF21 affects the development of obesity and metabolic disorders. It was found that FGF21 is associated with visceral obesity in patients with digestive diseases (odds ratio = 1.28, p = 0.0022). FGF21 levels above 1,317.5 pg/mL (sensitivity of 71.0 %, specificity of 53.1 %) indicate the presence of visceral obesity in patients with gastrointestinal diseases. Conclusions. As a result of a comprehensive study, new data were obtained on the role of FGF21 as a key regulator of metabolic disorders, which is confirmed by the established relationships of this indicator with the components of lipid and carbohydrate metabolism disorders, cytokine imbalance, and hormonal activity of adipose tissue in patients with pathology of the digestive system.
- Open Access
- 29 March 2024
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 58 (1) , 6-12
Predictors of visceral obesity among patients with pathology of the gastrointestinal tract
Background. In Ukraine, metabolic syndrome remains one of the most important problems of family medicine, it contributes to an increase in the prevalence of digestive diseases. Among the components of metabolic syndrome, researchers consider visceral obesity to be the most prognostically unfavorable. The purpose is to optimize diagnostic approaches to the formation of a risk group for the detection of visceral obesity in gastroenterology patients. Materials and methods. Eighty patients with gastrointestinal diseases were examined, 56 men (70.0 %) and 24 women (30.0 %). The age of the patients ranged from 18 to 66 years, with an average of (39.04 ± 1.03) years. TANITA MC-780MA body composition analyzer scales (Japan) were used to assess body structure. In all patients, serum levels of glucose, insulin, leptin, total cholesterol, triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) were determined, as well as low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), atherogenicity coefficient (AC) and homeostasis model assessment of insulin resistance (HOMA-IR). Results. Gastroenterological patients with visceral obesity had more pronounced changes in lipid and carbohydrate metabolism, which were characterized by a decrease in the content of HDL-C by 16.3 % (p < 0.05), an increase in TG by 41.9 % (p < 0.001), VLDL-C by 41.7 % (p < 0.01), AС by 41.6 % (p < 0.01), HOMA-IR by 28.0 % (p < 0.01) compared to patients without visceral obesity. According to the results of the correlation analysis, functional relationships were found between the amount of visceral fat and the level of leptin (r = 0.37; р = 0.0008), insulin (r = 0.41; р = 0.001), HOMA-IR (r = 0.48; р = 0.00001), TG (r = 0.452; р = 0.017), LDL-C (r = 0.383; р = 0.016), AС (r = 0.566; p < 0.001), TG/glucose ratio (r = 0.27; p = 0.0181), HDL-C (r = –0.448; p = 0.004). Determined predictors for the development of visceral obesity were as follows: triglycerides/high-density lipoprotein ratio (odds ratio (OR) 1.32; p = 0.0001), triglycerides/glucose ratio (OR 1.17; p = 0.0014), HOMA-IR (OR 1.26; p = 0.0013), atherogenicity coefficient (OR 1.13; p = 0.0001), leptin/triglycerides ratio (OR 1.35; p = 0.0014). Conclusions. The formation of a risk group for the detection of visceral obesity with the help of defined diagnostic criteria will allow to personalize the management of gastroenterology patients already at the primary level of medical care.
- 29 March 2024
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 58 (1) , 6-12
Open AccessPredictors of visceral obesity among patients with pathology of the gastrointestinal tract
Background. In Ukraine, metabolic syndrome remains one of the most important problems of family medicine, it contributes to an increase in the prevalence of digestive diseases. Among the components of metabolic syndrome, researchers consider visceral obesity to be the most prognostically unfavorable. The purpose is to optimize diagnostic approaches to the formation of a risk group for the detection of visceral obesity in gastroenterology patients. Materials and methods. Eighty patients with gastrointestinal diseases were examined, 56 men (70.0 %) and 24 women (30.0 %). The age of the patients ranged from 18 to 66 years, with an average of (39.04 ± 1.03) years. TANITA MC-780MA body composition analyzer scales (Japan) were used to assess body structure. In all patients, serum levels of glucose, insulin, leptin, total cholesterol, triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) were determined, as well as low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), atherogenicity coefficient (AC) and homeostasis model assessment of insulin resistance (HOMA-IR). Results. Gastroenterological patients with visceral obesity had more pronounced changes in lipid and carbohydrate metabolism, which were characterized by a decrease in the content of HDL-C by 16.3 % (p < 0.05), an increase in TG by 41.9 % (p < 0.001), VLDL-C by 41.7 % (p < 0.01), AС by 41.6 % (p < 0.01), HOMA-IR by 28.0 % (p < 0.01) compared to patients without visceral obesity. According to the results of the correlation analysis, functional relationships were found between the amount of visceral fat and the level of leptin (r = 0.37; р = 0.0008), insulin (r = 0.41; р = 0.001), HOMA-IR (r = 0.48; р = 0.00001), TG (r = 0.452; р = 0.017), LDL-C (r = 0.383; р = 0.016), AС (r = 0.566; p < 0.001), TG/glucose ratio (r = 0.27; p = 0.0181), HDL-C (r = –0.448; p = 0.004). Determined predictors for the development of visceral obesity were as follows: triglycerides/high-density lipoprotein ratio (odds ratio (OR) 1.32; p = 0.0001), triglycerides/glucose ratio (OR 1.17; p = 0.0014), HOMA-IR (OR 1.26; p = 0.0013), atherogenicity coefficient (OR 1.13; p = 0.0001), leptin/triglycerides ratio (OR 1.35; p = 0.0014). Conclusions. The formation of a risk group for the detection of visceral obesity with the help of defined diagnostic criteria will allow to personalize the management of gastroenterology patients already at the primary level of medical care.
- Open Access
- 29 September 2023
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 57 (3) , 135-140
Effects of visceral obesity on cytokine and hormonal regulation in patients with gastroesophageal reflux disease
Background. In recent years, pathogenetic mechanisms underlying the association of gastroesophageal reflux disease (GERD) and metabolic syndrome have caused considerable interest among researchers. The purpose is to determine the features of cytokine balance, carbohydrate metabolism, leptin and ghrelin levels depending on the amount of visceral fat in patients with GERD. Materials and methods. Fifty-six patients with GERD were examined. According to the results of bioimpedance analysis, they were divided into the groups: 23 patients with a dangerous and 33 with a safe amount of visceral fat. The levels of tumor necrosis factor α, interleukin-6, interleukin-10, ghrelin and leptin were determined in the blood serum of all patients by the enzyme immunoassay method. Also, the levels of glucose, insulin were determined and the insulin resistance index (HOMA-IR) was calculated in patients with GERD. Results. In the group of GERD patients with a dangerous amount of visceral fat, an increase in the concentration of the pro-inflammatory cytokine interleukin-6 by 12 % was found with a simultaneous decrease in the level of the anti-inflammatory cytokine interleukin-10 by 22 % (p < 0.05), an increase in the HOMA-IR median by 1.3 times (p < 0.05) compared to the patients with a safe amount of visceral fat. The median level of ghrelin in patients with a dangerous visceral fat amount increased significantly, by 2.0 times (p < 0.05) compared to the control group. Correlation analysis showed an association between visceral fat and leptin (r = 0.37; p = 0.0008), interleukin-10 (r = –0.28; p = 0.0116), insulin (r = 0.41; p = 0.001), HOMA-IR (r = 0.48; p = 0.00001). Conclusions. In GERD patients, an increase in the amount of visceral fat was associated with a violation of the cytokine balance, carbohydrate metabolism, increased level of ghrelin. The determined statistically significant correlation between the amount of visceral fat and the level of leptin indicates a functional relationship between the body composition according to bioimpedance analysis and the hormonal activity of adipose tissue in patients with GERD.
- 29 September 2023
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 57 (3) , 135-140
Open AccessEffects of visceral obesity on cytokine and hormonal regulation in patients with gastroesophageal reflux disease
Background. In recent years, pathogenetic mechanisms underlying the association of gastroesophageal reflux disease (GERD) and metabolic syndrome have caused considerable interest among researchers. The purpose is to determine the features of cytokine balance, carbohydrate metabolism, leptin and ghrelin levels depending on the amount of visceral fat in patients with GERD. Materials and methods. Fifty-six patients with GERD were examined. According to the results of bioimpedance analysis, they were divided into the groups: 23 patients with a dangerous and 33 with a safe amount of visceral fat. The levels of tumor necrosis factor α, interleukin-6, interleukin-10, ghrelin and leptin were determined in the blood serum of all patients by the enzyme immunoassay method. Also, the levels of glucose, insulin were determined and the insulin resistance index (HOMA-IR) was calculated in patients with GERD. Results. In the group of GERD patients with a dangerous amount of visceral fat, an increase in the concentration of the pro-inflammatory cytokine interleukin-6 by 12 % was found with a simultaneous decrease in the level of the anti-inflammatory cytokine interleukin-10 by 22 % (p < 0.05), an increase in the HOMA-IR median by 1.3 times (p < 0.05) compared to the patients with a safe amount of visceral fat. The median level of ghrelin in patients with a dangerous visceral fat amount increased significantly, by 2.0 times (p < 0.05) compared to the control group. Correlation analysis showed an association between visceral fat and leptin (r = 0.37; p = 0.0008), interleukin-10 (r = –0.28; p = 0.0116), insulin (r = 0.41; p = 0.001), HOMA-IR (r = 0.48; p = 0.00001). Conclusions. In GERD patients, an increase in the amount of visceral fat was associated with a violation of the cytokine balance, carbohydrate metabolism, increased level of ghrelin. The determined statistically significant correlation between the amount of visceral fat and the level of leptin indicates a functional relationship between the body composition according to bioimpedance analysis and the hormonal activity of adipose tissue in patients with GERD.
- Open Access
- 22 June 2023
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 57 (2) , 62-69
Metabolism of free fatty acids in patients with gastrointestinal diseases depending on the body mass index
Background. The purpose of the study is to analyze the content of free fatty acids (FFA) in the blood serum of overweight and underweight patients with gastrointestinal diseases. Materials and methods. Thirty-one patients with gastrointestinal diseases were examined, 19 (61.3 %) men and 12 (38.7 %) women with a median age of 39 (27; 48) years. Depending on the results of the body composition study with the multifunctional monitor TANITA MC-780MA (Japan), they were divided into the following groups: overweight patients (body mass index (BMI) more than 25.0 kg/m2) and underweight persons (BMI below 18.5 kg/m2). Determination of the FFA spectrum in the blood serum was carried out using a gas chromatograph with a flame ionization detector Chromatek-Crystal 5000. The control group consisted of 16 practically healthy people. Statistical processing of the results was carried out using the Statistica 6.1 application program package. Results. Patients with a change in body weight reported a statistically significant decrease in the median total content of short-chain saturated FFA (C4:0) mainly due to a decrease in the butyric acid content by 67 times (p = 0.001) with increased BMI and by 114 times (p = 0.002) with decreased BMI compared to controls. At the same time, the analysis of the serum spectrum of saturated FFA with an average carbon chain length showed a probable increase in the content of capric acid by 14 times (p < 0.01), undecyl acid by 19 times (p < 0.01), and lauric acid by 25 times (p < 0.001) in patients with changes in body weight. The content of caproic acid increased in the group with excessive body weight by 3.9 times (p = 0.046) compared to controls and by 2.6 times (p > 0.05) compared to underweight patients. The total content of monounsaturated FFA in the blood serum of patients with increased and decreased BMI increased significantly by 32 times (p < 0.001) and 19 times (p = 0.001), respectively, compared to controls. The total content of polyunsaturated FFA in the blood serum of patients of both groups was found in a trace amount. Overweight patients had a 38-fold (p < 0.01) increase in the trans-FFA elaidic acid (C18:1(trans-9)) compared to controls, while underweight patients had a decrease in linoelaidic acid (C18:2(trans-9,12)) by 11.7 times (p < 0.05). Correlation analysis revealed a positive relationship between BMI and increased serum content of saturated caproic acid (r = 0.39; p = 0.019); monounsaturated acids — palmitoleic (r = 0.33; р = 0.045) and heptadecenoic (r = 0.35; р = 0.034); trans-configuration fatty acids — elaidic (r = 0.43; p = 0.009) and linoelaidic (r = 0.43; p = 0.007). Conclusions. Patients with gastrointestinal diseases had an imbalance in the fatty acid spectrum of the blood serum. Against the background of the tendency to decrease the total content of short-chain saturated FFA, a significant increase in the content of monounsaturated FFA and trans-FFA was noted, especially with increased BMI. In all patients, the trace amount of polyunsaturated FFA fractions was found. The obtained results can be used to improve the differential treatment of metabolic disorders in patients with gastrointestinal tract pathology.
- 22 June 2023
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 57 (2) , 62-69
Open AccessMetabolism of free fatty acids in patients with gastrointestinal diseases depending on the body mass index
Background. The purpose of the study is to analyze the content of free fatty acids (FFA) in the blood serum of overweight and underweight patients with gastrointestinal diseases. Materials and methods. Thirty-one patients with gastrointestinal diseases were examined, 19 (61.3 %) men and 12 (38.7 %) women with a median age of 39 (27; 48) years. Depending on the results of the body composition study with the multifunctional monitor TANITA MC-780MA (Japan), they were divided into the following groups: overweight patients (body mass index (BMI) more than 25.0 kg/m2) and underweight persons (BMI below 18.5 kg/m2). Determination of the FFA spectrum in the blood serum was carried out using a gas chromatograph with a flame ionization detector Chromatek-Crystal 5000. The control group consisted of 16 practically healthy people. Statistical processing of the results was carried out using the Statistica 6.1 application program package. Results. Patients with a change in body weight reported a statistically significant decrease in the median total content of short-chain saturated FFA (C4:0) mainly due to a decrease in the butyric acid content by 67 times (p = 0.001) with increased BMI and by 114 times (p = 0.002) with decreased BMI compared to controls. At the same time, the analysis of the serum spectrum of saturated FFA with an average carbon chain length showed a probable increase in the content of capric acid by 14 times (p < 0.01), undecyl acid by 19 times (p < 0.01), and lauric acid by 25 times (p < 0.001) in patients with changes in body weight. The content of caproic acid increased in the group with excessive body weight by 3.9 times (p = 0.046) compared to controls and by 2.6 times (p > 0.05) compared to underweight patients. The total content of monounsaturated FFA in the blood serum of patients with increased and decreased BMI increased significantly by 32 times (p < 0.001) and 19 times (p = 0.001), respectively, compared to controls. The total content of polyunsaturated FFA in the blood serum of patients of both groups was found in a trace amount. Overweight patients had a 38-fold (p < 0.01) increase in the trans-FFA elaidic acid (C18:1(trans-9)) compared to controls, while underweight patients had a decrease in linoelaidic acid (C18:2(trans-9,12)) by 11.7 times (p < 0.05). Correlation analysis revealed a positive relationship between BMI and increased serum content of saturated caproic acid (r = 0.39; p = 0.019); monounsaturated acids — palmitoleic (r = 0.33; р = 0.045) and heptadecenoic (r = 0.35; р = 0.034); trans-configuration fatty acids — elaidic (r = 0.43; p = 0.009) and linoelaidic (r = 0.43; p = 0.007). Conclusions. Patients with gastrointestinal diseases had an imbalance in the fatty acid spectrum of the blood serum. Against the background of the tendency to decrease the total content of short-chain saturated FFA, a significant increase in the content of monounsaturated FFA and trans-FFA was noted, especially with increased BMI. In all patients, the trace amount of polyunsaturated FFA fractions was found. The obtained results can be used to improve the differential treatment of metabolic disorders in patients with gastrointestinal tract pathology.
- Open Access
- 30 April 2023
- Published by Publishing Company VIT-A-POL in Modern Gastroenterology
- No. 2,p. 59-66
Gastroesophageal reflux disease in conditions of chronic stress. Review with own observation
It is known that 20 to 42% of patients receiving a proton pump inhibitor for the treatment of gastroesophageal reflux disease do not respond satisfactorily to it. This condition is called refractory gastroesophageal reflux disease. To achieve a therapeutic effect, it is advised to use H2‑receptor antagonists, alginates, baclofen or antidepressant therapy in complex treatment. Recent years, solutions containing sodium alginate have been widely used. These drugs reduce the severity and frequency of heartburn when used postprandially as adjunctive therapy to proton pump inhibitors in patients with gastroesophageal reflux disease. The alginates, available in the US and European markets, differ, with the latter containing higher concentrations of alginate, possibly contributing to higher efficiency. This is supported by some researchers reporting rapid efficacy for both postprandial and nocturnal symptoms in patients with refractory gastroesophageal reflux disease. Given the absence of significant side effects, it is advised to use alginates as an addition to proton pump inhibitors, taking into account the availability, as well as the preferences of the doctor and patient. The article presents modern scientific data on a widespread Gastroenterological disease — GERD in the context of the impact of stress factor on its course. The analysis was performed of the recent investigations, aimed at the study of the mechanisms of traumatic effect of psychosocial and psychoemotional stress on the functional activity of the upper gastrointestinal tract. The results of the study of the role of anxiety‑phobic and depressive disorders because of prolonged exposure to stressors were analyzed. The author presented data of his own research, which clearly demonstrated a significant increase of frequency and level of anxiety and depression under wartime stress. It has been established that combination of gastroesophageal reflux disease with anxiety and depression exacerbates the clinical manifestations of the disease and reduces the effectiveness of treatment, which requires an individual approach to the choice of therapeutic measures. It is advisable to use antacids and alginic acid preparations, as well as methods of psychological correction, along with proton pump inhibitors or instead of them.
- 30 April 2023
- Published by Publishing Company VIT-A-POL in Modern Gastroenterology
- No. 2,p. 59-66
Open AccessGastroesophageal reflux disease in conditions of chronic stress. Review with own observation
It is known that 20 to 42% of patients receiving a proton pump inhibitor for the treatment of gastroesophageal reflux disease do not respond satisfactorily to it. This condition is called refractory gastroesophageal reflux disease. To achieve a therapeutic effect, it is advised to use H2‑receptor antagonists, alginates, baclofen or antidepressant therapy in complex treatment. Recent years, solutions containing sodium alginate have been widely used. These drugs reduce the severity and frequency of heartburn when used postprandially as adjunctive therapy to proton pump inhibitors in patients with gastroesophageal reflux disease. The alginates, available in the US and European markets, differ, with the latter containing higher concentrations of alginate, possibly contributing to higher efficiency. This is supported by some researchers reporting rapid efficacy for both postprandial and nocturnal symptoms in patients with refractory gastroesophageal reflux disease. Given the absence of significant side effects, it is advised to use alginates as an addition to proton pump inhibitors, taking into account the availability, as well as the preferences of the doctor and patient. The article presents modern scientific data on a widespread Gastroenterological disease — GERD in the context of the impact of stress factor on its course. The analysis was performed of the recent investigations, aimed at the study of the mechanisms of traumatic effect of psychosocial and psychoemotional stress on the functional activity of the upper gastrointestinal tract. The results of the study of the role of anxiety‑phobic and depressive disorders because of prolonged exposure to stressors were analyzed. The author presented data of his own research, which clearly demonstrated a significant increase of frequency and level of anxiety and depression under wartime stress. It has been established that combination of gastroesophageal reflux disease with anxiety and depression exacerbates the clinical manifestations of the disease and reduces the effectiveness of treatment, which requires an individual approach to the choice of therapeutic measures. It is advisable to use antacids and alginic acid preparations, as well as methods of psychological correction, along with proton pump inhibitors or instead of them.
- Open Access
- 27 March 2023
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 57 (1) , 1-10
Xanthomas and precancerous changes of the stomach: an accidental combination or an important prognostic endoscopic marker?
Background. The article deals with the study of gastric xanthomas, benign accidental formations with an unknown etiopathogenesis, which, according to the literature, are associated with a number of pathological conditions (atrophic gastritis, intestinal metaplasia, dysplasia, gastric cancer, dyslipidemia, etc.). The purpose was to study the prevalence of gastric xanthomas in patients with atrophic gastritis and to analyze their relationship with endoscopic changes in the stomach, including precancerous conditions. Materials and methods. Esophagogastroduodenoscopy was performed using the EVIS EXERA III video endoscopy system with the Olympus 190 gastroscope (Japan) in 120 patients with atrophic gastritis undergoing examination and treatment at the Institute of Gastroenterology of the National Academy of Sciences of Ukraine. The presence of duodenogastric reflux, the prevalence and severity of mucosal atrophy, changes in the relief of the gastric mucosa (including nodules and bumps), the presence of hyperplasia, polyps, hemorrhages, erosions, ulcers, xanthomas in the stomach were assessed. When using the narrow-band imaging and close focus, the presence and prevalence of intestinal metaplasia, the presence of gastric dysplasia were evaluated. Comparative and statistical analysis of endoscopic data was conducted depending on the presence of gastric xanthomas. Results. The heterogeneity of endoscopic changes in atrophic gastritis was revealed (prevalence and severity of atrophy, intestinal metaplasia, changes in the mucosal relief, presence of hyperplasia, polyps, ulcers, etc.). Gastric xanthomas were found in more than a third of patients with atrophic gastritis (36.7 % of cases), with predominant localization in the antral region (90.9 %). As a rule (95.5 %), they were single. In patients with atrophic gastritis associated with xanthomas, diffuse atrophic changes in gastric mucosa were detected significantly more often, as well as mucosal nodules and bumps, mucosal hyperplasia, intestinal metaplasia and the mucosal dysplasia, which was confirmed morphologically (p < 0.05). Rare cases of gastric ulcers and gastric cancer were diagnosed only in patients with xanthomas (p > 0.05). Conclusions. The obtained results indicate that gastric xanthoma is an important diagnostic marker of precancerous changes in the gastric mucosa: widespread atrophy, intestinal metaplasia, dysplasia, and can be used as an important prognostic marker for the development of gastric cancer. Patients with xanthoma-associated atrophic gastritis require a thorough examination using modern endoscopic equipment and dynamic observation, with a focus on changes in the gastric relief by the type of nodules and bumps.
- 27 March 2023
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 57 (1) , 1-10
Open AccessXanthomas and precancerous changes of the stomach: an accidental combination or an important prognostic endoscopic marker?
Background. The article deals with the study of gastric xanthomas, benign accidental formations with an unknown etiopathogenesis, which, according to the literature, are associated with a number of pathological conditions (atrophic gastritis, intestinal metaplasia, dysplasia, gastric cancer, dyslipidemia, etc.). The purpose was to study the prevalence of gastric xanthomas in patients with atrophic gastritis and to analyze their relationship with endoscopic changes in the stomach, including precancerous conditions. Materials and methods. Esophagogastroduodenoscopy was performed using the EVIS EXERA III video endoscopy system with the Olympus 190 gastroscope (Japan) in 120 patients with atrophic gastritis undergoing examination and treatment at the Institute of Gastroenterology of the National Academy of Sciences of Ukraine. The presence of duodenogastric reflux, the prevalence and severity of mucosal atrophy, changes in the relief of the gastric mucosa (including nodules and bumps), the presence of hyperplasia, polyps, hemorrhages, erosions, ulcers, xanthomas in the stomach were assessed. When using the narrow-band imaging and close focus, the presence and prevalence of intestinal metaplasia, the presence of gastric dysplasia were evaluated. Comparative and statistical analysis of endoscopic data was conducted depending on the presence of gastric xanthomas. Results. The heterogeneity of endoscopic changes in atrophic gastritis was revealed (prevalence and severity of atrophy, intestinal metaplasia, changes in the mucosal relief, presence of hyperplasia, polyps, ulcers, etc.). Gastric xanthomas were found in more than a third of patients with atrophic gastritis (36.7 % of cases), with predominant localization in the antral region (90.9 %). As a rule (95.5 %), they were single. In patients with atrophic gastritis associated with xanthomas, diffuse atrophic changes in gastric mucosa were detected significantly more often, as well as mucosal nodules and bumps, mucosal hyperplasia, intestinal metaplasia and the mucosal dysplasia, which was confirmed morphologically (p < 0.05). Rare cases of gastric ulcers and gastric cancer were diagnosed only in patients with xanthomas (p > 0.05). Conclusions. The obtained results indicate that gastric xanthoma is an important diagnostic marker of precancerous changes in the gastric mucosa: widespread atrophy, intestinal metaplasia, dysplasia, and can be used as an important prognostic marker for the development of gastric cancer. Patients with xanthoma-associated atrophic gastritis require a thorough examination using modern endoscopic equipment and dynamic observation, with a focus on changes in the gastric relief by the type of nodules and bumps.